Remedica has been named for a second consecutive year as ‘Ones to Watch’ in Europe in a list of business excellence published by the European Business Awards, one of the world’s largest and longest running business competitions.
Remedica was chosen for this title as it is recognised for its exceptional achievements in one of the 18 European Business Awards’ categories and reflects the programme’s core values of innovation, success and ethics.
Remedica is a leading pharmaceutical company located in Cyprus, which exports in more than 100 countries. Originally founded in 1960 by Mr Chris Pattichis as a CO2 manufacturer, today is specialising in the development, production and sale of high-quality, safe and efficacious pharmaceutical products for human use. Today, its portfolio consists of more than 300 pharmaceutical products. Dr Michael Neoptolemou, Group CEO of Remedica said: “We are very proud to have been selected as ‘Ones to Watch’ in Europe in The European Business Awards, which are widely recognised as the showcase for Europe’s most dynamic companies”.
Mr. Adrian Tripp, CEO of the European Business Awards, said: “The companies chosen as ‘Ones to Watch’ are the most inspirational, successful and dynamic in Europe”. He continued: “The talent and tenacity at the heart of these businesses creates jobs and drives Europe’s prosperity. This ‘Ones to Watch’ list of excellence is a benchmark of success for the rest of the European business community.”
Remedica will now have the chance to compete in one of the 18 categories of this year’s European Business Awards to become a National Winner. If successful, it will then take part in the Gala Final in December 2019, where the final 18 European winners will be announced.
About the European Business Awards:
The primary purpose of the European Business is to support and develop a stronger, more successful, innovative and ethical business community in Europe. It aims to do that in 3 ways:
- Endorsing and promoting Europe’s best businesses
- Sharing, learning and solving problems
- Stimulating debates